These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 31234870)

  • 1. ARL3 is downregulated and acts as a prognostic biomarker in glioma.
    Wang Y; Zhao W; Liu X; Guan G; Zhuang M
    J Transl Med; 2019 Jun; 17(1):210. PubMed ID: 31234870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine learning-based identification of a cell death-related signature associated with prognosis and immune infiltration in glioma.
    Zhou Q; Wu F; Zhang W; Guo Y; Jiang X; Yan X; Ke Y
    J Cell Mol Med; 2024 Jun; 28(11):e18463. PubMed ID: 38847472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cuproptosis-based prognostic model for predicting survival in low-grade glioma.
    Zhao Z; Ma Y; Liu Y; Chen Z; Zheng J
    Aging (Albany NY); 2024 May; 16(10):8697-8716. PubMed ID: 38738989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cuproptosis-related gene-located DNA methylation in lower-grade glioma: Prognosis and tumor microenvironment.
    Zhu L; Yuan F; Wang X; Zhu R; Guo W
    Cancer Biomark; 2024; 40(2):185-198. PubMed ID: 38578883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and validation of a risk signature based on extracellular matrix-related genes in gliomas.
    Liu J; Li G
    Medicine (Baltimore); 2021 Apr; 100(16):e25603. PubMed ID: 33879726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel pyroptosis-related gene signature predicts the prognosis of glioma through immune infiltration.
    Zhang M; Cheng Y; Xue Z; Sun Q; Zhang J
    BMC Cancer; 2021 Dec; 21(1):1311. PubMed ID: 34876094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a ferroptosis-related prognostic signature and validation of ITGA6-AS1 in enhancing cell proliferation, migration and invasion in glioma.
    Jiang M; Liu Y; Zhang T; Ye G; Hong S; Qi Z
    Int Immunopharmacol; 2024 Aug; 137():112438. PubMed ID: 38875999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ITGB2 as a prognostic indicator and a predictive marker for immunotherapy in gliomas.
    Xu H; Zhang A; Han X; Li Y; Zhang Z; Song L; Wang W; Lou M
    Cancer Immunol Immunother; 2022 Mar; 71(3):645-660. PubMed ID: 34313821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EPHB2 as a key mediator of glioma progression: Insights from microenvironmental receptor ligand-related prognostic gene signature.
    Tan L; Zhou J; Nie Z; Li D; Wang B
    Genomics; 2024 May; 116(3):110799. PubMed ID: 38286348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysyl oxidase-like 1 predicts the prognosis of patients with primary glioblastoma and promotes tumor invasion
    Yuan GQ; Zhang G; Nie Q; Wang Z; Gao HZ; Jin GS; Zheng ZQ
    PeerJ; 2024; 12():e17579. PubMed ID: 38978755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-cohort comprehensive analysis unveiling the clinical value and therapeutic effect of
    Liu Z; Yang L; Xie Z; Yu H; Gu T; Shi D; Cai N; Zhuo S
    Oncol Res; 2024; 32(5):965-981. PubMed ID: 38686055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and clinical characterization of PARP9 in gliomas: A potential immunotherapeutic target.
    Xu H; Chai S; Wang Y; Wang J; Xiao D; Li J; Xiong N
    CNS Neurosci Ther; 2020 Aug; 26(8):804-814. PubMed ID: 32678519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel 10-Gene Signature Predicts Poor Prognosis in Low Grade Glioma.
    Liu W; Zou J; Ren R; Liu J; Zhang G; Wang M
    Technol Cancer Res Treat; 2021; 20():1533033821992084. PubMed ID: 33550903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pan-cancer multi-omics analysis of PTBP1 reveals it as an inflammatory, progressive and prognostic marker in glioma.
    Ye Z; Zhong Y; Zhang Z
    Sci Rep; 2024 Jun; 14(1):14584. PubMed ID: 38918441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and Prognostic Role of PANK1 in Glioma.
    Zhao Z; Xu X; Ma S; Li L
    Comb Chem High Throughput Screen; 2024; 27(5):715-724. PubMed ID: 37138430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHI3L1 as a Prognostic Biomarker and Therapeutic Target in Glioma.
    Zhou J; Zhao D; Tan H; Lan J; Bao Y
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COL8A1 is a potential prognostic biomarker associated with migration, proliferation, and tumor microenvironment in glioma.
    Liu M; Liang W; Su Y; Wen Y; Qi J; Wang L; Su S; Zhao J; Shan J; Wang J
    Exp Cell Res; 2024 Jun; 439(1):114076. PubMed ID: 38719174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Significance of the Redox Gene in the Prognosis and Therapeutic Response of Glioma.
    Niu H; Cao H; Liu X; Chen Y; Cheng Z; Long J; Li F; Sun C; Zuo P
    Am J Clin Oncol; 2024 Jun; 47(6):259-270. PubMed ID: 38318849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HOXD9 is a potential prognostic biomarker involved in immune microenvironment of glioma.
    Xu S; Xiao H; Song T; Zeng Y; Wei C; Chen T; Hu Z; Guo R; Li D; Jiang M
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):14911-14926. PubMed ID: 37603105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated SLC3A2 associated with poor prognosis and enhanced malignancy in gliomas.
    Xu Y; Weng W; Weng Y; Chen D; Zheng Z; Fan Z; Peng C; Xiong Y; Pang X; Cao G; Wang Y; Mo Q; Wang Z; Zhang S
    Sci Rep; 2024 Jul; 14(1):15758. PubMed ID: 38977800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.